Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.
about
Management of atopic dermatitis: safety and efficacy of phototherapyImmune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted TherapeuticsDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesNew era of biologic therapeutics in atopic dermatitisThe ABC's of managing patients with severe atopic dermatitisCyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Comparing performance of Chromameter®, Mexameter® and full-field laser perfusion imaging for measurement of ultraviolet B light-induced erythema.Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathwaysConsensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitisT Helper 1 and T Helper 2 Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human KeratinocytesHeat-Killed Enterococcus faecalis EF-2001 Ameliorates Atopic Dermatitis in a Murine Model.Inhibition of inflammatory reactions in 2,4-Dinitrochlorobenzene induced Nc/Nga atopic dermatitis mice by non-thermal plasmaPathways to managing atopic dermatitis: consensus from the expertsAtopic dermatitis and vitamin D: facts and controversies.Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.Role of vitamin D in the pathogenesis and treatment of atopic dermatitis.Apremilast for the treatment of psoriatic arthritis.Treatment of Eczema: Corticosteroids and Beyond.Drug evaluation review: dupilumab in atopic dermatitis.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.Atopic dermatitis in older adults: A viewpoint from geriatric dermatology.Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers.Baicalein increases keratin 1 and 10 expression in HaCaT keratinocytes via TRPV4 receptor activation.Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues.AhR mediates an anti-inflammatory feedback mechanism in human Langerhans cells involving FcεRI and IDO.Phototherapy in Atopic Dermatitis.A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903.
P2860
Q26778443-718560DB-B5D0-4512-B709-CBFDC5D7F1EAQ26799532-421E21B3-3BFB-4935-8F31-D7EE07CA94A5Q26852335-A270D828-7E90-4AE3-8F08-96A34B38E957Q27001941-99FD589F-F6EA-4C7B-943D-4FD6C500BF5FQ27022610-FC931615-F0F7-4886-A36C-ABD353D2A64DQ34006054-C10E19E6-8ABC-456A-A808-05C94A4AE7F3Q34797596-66CC5441-9DFA-49A0-998C-99CD0A4460E8Q35561678-11B7E03D-F9D3-4E2E-AA29-91B5B4911039Q35803992-B714DBA8-C037-4092-AAF8-1203D94F1077Q36214254-E85034B6-E691-4D36-B60B-6A98FC03E24BQ36580238-6EE9009B-050D-4A78-86CA-82952750BC83Q36705578-04FE3DDC-8508-4B3B-975B-860E040A3EBCQ36732085-628FAE80-E9AE-4D54-93C2-602E01D85502Q36980186-7EF6ECE8-3520-4C4F-A2E0-743C7CC250CAQ37258723-67595C18-4004-4443-AED8-30DB16CB06C5Q37509446-5958AD3A-DC44-44F3-9D8A-5CE280AE4722Q37709674-831B7D18-54AC-4886-866F-CFA1B410739DQ38124385-617B26E6-2294-4EA4-A04E-CD664C2353CBQ38131033-BAFE79F7-5C71-4643-94C8-0236FA646FD4Q38202205-E7CE8CD7-7F55-403C-91EF-C71775EEEDABQ38419338-9694D9AE-7A8E-4B62-8F34-24391215B173Q38645192-5A1EBD63-2B3C-4A6E-A686-A22055174471Q38733182-C52FA3B7-3881-425B-8A00-D66361021786Q38790589-52343D9C-7A82-498F-9A54-5AAA5A4413F9Q38793743-1D4D6CF1-B92A-4E37-B55A-B66C66F9D1F2Q46566713-028C08BC-7BE8-41E8-90B0-C462BAFD5A36Q47171494-F6C51775-6BE9-4878-8841-091A21090AACQ47865957-A7B776C5-37B6-43C6-8025-68390C15135EQ48205671-AFFA6CE6-DFA1-4950-A272-93EADFB2DA32Q48298664-900C44A9-BECD-4A63-87EA-44D8599C880EQ48321721-79A418A3-08A3-4E14-8E18-D41CC4F39767Q50074897-0850DA97-D09D-4944-8754-84BF33B7EBE4Q52930714-91CC3A7F-5B17-4832-85B9-18934921EDAD
P2860
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Reversal of atopic dermatitis ...... kers for therapeutic response.
@ast
Reversal of atopic dermatitis ...... kers for therapeutic response.
@en
Reversal of atopic dermatitis ...... kers for therapeutic response.
@nl
type
label
Reversal of atopic dermatitis ...... kers for therapeutic response.
@ast
Reversal of atopic dermatitis ...... kers for therapeutic response.
@en
Reversal of atopic dermatitis ...... kers for therapeutic response.
@nl
prefLabel
Reversal of atopic dermatitis ...... kers for therapeutic response.
@ast
Reversal of atopic dermatitis ...... kers for therapeutic response.
@en
Reversal of atopic dermatitis ...... kers for therapeutic response.
@nl
P2093
P2860
P1476
Reversal of atopic dermatitis ...... kers for therapeutic response.
@en
P2093
Andrea Chiricozzi
Avner Shemer
Emma Guttman-Yassky
Hideki Fujita
Irma Cardinale
James G Krueger
Leanne Johnson-Huang
Mary Sullivan-Whalen
Mayte Suárez-Fariñas
Patricia Gilleaudeau
P2860
P304
583-93.e1-4
P356
10.1016/J.JACI.2011.05.042
P407
P577
2011-07-16T00:00:00Z